💨 Abstract
GSK reported second-quarter earnings of $1.93 billion, with a profit of 94 cents per share. After adjusting for non-recurring costs, earnings were $1.23 per share, surpassing Wall Street expectations of $1.12 per share. Revenue for the period was $10.67 billion, exceeding forecasts of $10.33 billion. This strong performance indicates positive market sentiment towards the London-based drug developer.
Courtesy: WTOP Staff
Suggested
First Australian-made rocket crashes after 14 seconds of flight in a failed attempt to reach orbit -
Cambodians return to scenes of destruction after fleeing border fighting with Thailand -
McDonald scores a career-high 27 and the short-handed Fever beat the Mercury for 3rd straight win -
Cubs add depth to rotation by acquiring Michael Soroka from Nationals, AP source says -
Hillmon hits tiebreaking 3 with 2.6 seconds left, scores career-high 21 points as Dream beat Wings -
Messi’s last-second assist lifts Inter Miami over Atlas 2-1 in Leagues Cup -
Steer’s 2-run triple in 8th helps Reds beat Dodgers 5-2 after Ohtani’s outing cut short -
Senate rejects bid to halt sale of bombs and rifles to Israel, but Democratic opposition grows -
Police arrest a 28-year-old Arkansas man in the killings of a married couple hiking at Devil’s Den State Park -
What to know about the fatal attack of a married couple at Devil’s Den park in Arkansas -